NetworkNewsBreaks – Pressure BioSciences Inc.’
Post# of 1354
(Total Views: 204)
Posted On: 10/01/2019 5:19:11 PM
NetworkNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Fills Integral Role for Tumor Analyses in Novel Workflow Presented at IGCS
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that its patented pressure cycling technology (“PCT”) platform was featured as an integral part of an innovative new workflow for the analysis of proteins from cancer biopsy samples. The workflow was presented during a plenary session at the Annual Meeting of the International Gynecologic Cancer Society (“IGCS”) on September 21, 2019 in Rio de Janeiro, Brazil. According to the update, Dr. Thomas Conrads, a nationally acclaimed protein chemist and the senior director of Women’s Health Research at the Inova Women’s Hospital, and his colleagues developed the novel workflow. “We are very pleased to have been invited to present the results of our work in gynecologic cancer research in a plenary session at this important international meeting,” Dr. Conrads commented in the news release. “The novel workflow developed by our group integrates and operationalizes state-of-the art techniques: laser microdissection (“LMD”), pressure cycling technology (“PCT”), and mass spectrometry (“MS”) to improve our understanding of the complex tissue microenvironment and, in this case, to enable identification of biomarkers associated with women’s cancers. We believe that the insights we gain from applying this novel workflow will result in significant improvements in the clinical management of gynecologic cancer.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that its patented pressure cycling technology (“PCT”) platform was featured as an integral part of an innovative new workflow for the analysis of proteins from cancer biopsy samples. The workflow was presented during a plenary session at the Annual Meeting of the International Gynecologic Cancer Society (“IGCS”) on September 21, 2019 in Rio de Janeiro, Brazil. According to the update, Dr. Thomas Conrads, a nationally acclaimed protein chemist and the senior director of Women’s Health Research at the Inova Women’s Hospital, and his colleagues developed the novel workflow. “We are very pleased to have been invited to present the results of our work in gynecologic cancer research in a plenary session at this important international meeting,” Dr. Conrads commented in the news release. “The novel workflow developed by our group integrates and operationalizes state-of-the art techniques: laser microdissection (“LMD”), pressure cycling technology (“PCT”), and mass spectrometry (“MS”) to improve our understanding of the complex tissue microenvironment and, in this case, to enable identification of biomarkers associated with women’s cancers. We believe that the insights we gain from applying this novel workflow will result in significant improvements in the clinical management of gynecologic cancer.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼